Quarterly report pursuant to Section 13 or 15(d)

Cash, Cash Equivalents, Restricted Cash and Marketable Securities (Tables)

v3.20.2
Cash, Cash Equivalents, Restricted Cash and Marketable Securities (Tables)
9 Months Ended
Sep. 30, 2020
Cash and Cash Equivalents [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the Condensed Consolidated Balance Sheets to the total of the amounts in the Condensed Consolidated Statements of Cash Flows as of September 30, 2020, December 31, 2019, September 30, 2019 and December 31, 2018:

 

 

    September 30,
2020
    December 31,
2019
    September 30,
2019
    December 31,
2018
 
Cash and cash equivalents   $ 7,051     $ 22,170     $ 32,665     $ 12,447  
Restricted cash included in current/long term assets     386       586       586       561  
Cash, cash equivalents and restricted cash in the statement of cash flows   $ 7,437     $ 22,756     $ 33,251     $ 13,008  

 

Summary of Cash, Cash Equivalents and Marketable Securities

The following tables summarizes the Company’s marketable securities as of September 30, 2020:

 

    Amortized     Unrealized     Unrealized        
    Cost     Gain     (Loss)     Fair Value  
U.S. Treasury Bonds   $ 25,575     $ 220     $     $ 25,795  
U.S. Government Notes     22,305       116       (1 )     22,420  
Corporate Debt Securities     6,201       19             6,220  
State and Municipal Bonds     1,275       10             1,285  
Total marketable securities   $ 55,356     $ 365     $ (1 )   $ 55,720  
Schedule of Maturities of Debt Securities Available-for-sale

Maturities of debt securities classified as available-for-sale were as follows at September 30, 2020:

 

          Net Carrying  
    Fair Value     Amount  
Due within one year   $ 33,547     $ 33,726  
Due after one year through five years     22,173       22,225  
    $ 55,720     $ 55,951  

Summary of Cash, Cash Equivalents and Marketable Securities

The following tables summarizes the Company’s cash, cash equivalents and marketable securities for the year ended December 31, 2019:

 

    Amortized     Unrealized     Unrealized        
    Cost     Gain     (Loss)     Fair Value  
Cash and cash equivalents   $ 22,169     $ 1     $     $ 22,170  
                                 
U.S. Treasury Bonds   $ 4,003     $     $ (1 )   $ 4,002  
Corporate Debt Securities     1,604             (1 )     1,603  
Total marketable securities   $ 5,607     $     $ (2 )   $ 5,605  
                                 
Total cash, cash equivalents and marketable securities   $ 27,776     $ 1     $ (2 )   $ 27,775  

Schedule of Maturities of Debt Securities Available-for-sale

Maturities of debt securities classified as available-for-sale were as follows at December 31, 2019:

 

          Net Carrying  
    Fair Value     Amount  
Due within one year   $ 5,002     $ 5,019  
Due after one year through five years     603       607  
    $ 5,605     $ 5,626